TrialAmerican journal of clinical dermatology2023

Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.

Tadashi Terui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.